ClinicalTrials.gg
RecruitingNCT07685496Updated Oct 23, 2026

Impact of Footwear on Gait in Unilateral Transtibial Amputees

An interventional study of Own Footwear and Oxford Shoe in Transtibial Amputation, Lower Limb Amputation and Prosthesis Users, sponsored by University of Salford. Recruiting at 1 site in United Kingdom. Open to participants aged 18 Years to 65 Years. Per ClinicalTrials.gov, last updated 2026-10-23.

Sponsored by University of Salford · Not applicable, Interventional, and Basic science

Updated Oct 23, 2026Start date movedGo to Updates ↓
Phase
Not applicable
Study type
Interventional
Enrollment
15
Allocation
Randomized
Ages
18 Years to 65 Years
Sex
All
01

Study summary

The goal of this interventional study is to learn how different types of footwear affect gait, stability, comfort, and walking performance in adults with a unilateral transtibial amputation who use a lower limb prosthesis.

The main questions it aims to answer are:

  • Does footwear type affect gait characteristics such as gait speed, stride length, cadence, prosthetic foot clearance, and stance phase duration?
  • Does footwear type affect kinetic measures such as ground reaction forces and ankle power variables during walking?
  • Does footwear type affect in-shoe plantar pressure distribution?
  • Do participants perceive differences in comfort and stability between footwear conditions?

Participants will:

  • Attend a laboratory-based gait analysis session at the University of Salford.
  • Complete walking tasks while wearing four footwear conditions: their own preferred footwear, an Oxford shoe, a running/walking shoe, and a shoe with a forefoot rocker profile.
  • Perform straight-line walking, incline and decline walking, and S-shaped walking tasks.
  • Wear reflective markers and in-shoe pressure sensors during testing.
  • Complete visual analogue scale ratings of comfort and stability for each footwear condition.
Read the detailed description

People with transtibial amputations often rely on footwear that is comfortable, practical, and compatible with their prosthetic device. Although footwear is known to influence walking mechanics in the general population, there is limited evidence regarding its effects on gait in people who use lower limb prostheses. This study aims to investigate the impact of different footwear types on gait performance, stability, and comfort in adults with unilateral transtibial amputations.

Fifteen participants aged 18 to 65 years who use an energy-storing-and-return (ESAR) prosthetic foot will be recruited. Participants must be able to walk independently without a walking aid.

Each participant will attend a laboratory-based testing session at the University of Salford. Reflective markers will be placed on the body and prosthesis to allow three-dimensional motion analysis. Participants will also wear an in-shoe pressure measurement system.

Participants will complete a series of walking tasks while wearing four footwear conditions: their own preferred footwear, an Oxford shoe, a running/walking shoe, and a shoe with a forefoot rocker profile. The order of the footwear conditions will be randomised. Walking tasks will include straight-line walking, walking on an incline and decline, and walking along an S-shaped path involving turns.

Outcome measures will include gait speed, stride length, cadence, prosthetic foot clearance, stance phase duration, ground reaction forces, ankle power variables, and plantar pressure measurements. Participants will also rate the comfort and stability of each footwear condition using visual analogue scales and provide additional comments about their experience.

Data will be analysed to determine whether footwear type influences gait performance, stability, and perceived comfort in people with unilateral transtibial amputations. The findings may contribute to future clinical guidance and footwear recommendations for prosthetic users.

02

Conditions studied

  • Transtibial Amputation
  • Lower Limb Amputation
  • Prosthesis Users

Keywords

  • Footwear
  • Prosthetics
  • Transtibial Amputation
  • Gait Analysis
  • Walking
  • Balance
  • Stability
  • Prosthetic Limb
  • Lower Limb Prosthesis
03

In context

Lead sponsor

University of Salford is the lead sponsor of 27 studies on the registry; 2 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 65 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Individuals with a unilateral transtibial amputation.
  • Age 18 to 65 years.
  • Participants must use an energy-storing and return (ESAR) prosthetic foot.
  • Able to walk and stand without the use of walking aids.
  • Absence of comorbidities known to impact balance and mobility.

Exclusion criteria

Exclusion Criteria:

  • Bilateral amputees or individuals with amputation levels other than transtibial.
  • Individuals under 18 years or over 65 years of age.
  • Use of any prosthetic foot type other than ESAR.
  • Individuals unable to provide .
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Basic science
Allocation
Randomized
Intervention model
Crossover assignment
Masking
None (open label)
Enrollment
15 participants (estimated)

Study arms

  • Active comparator
    Own Footwear

    Participants complete walking and balance assessments while wearing their own regularly used footwear.

    Device: Own Footwear

  • Experimental
    Oxford Shoe

    Participants complete walking and balance assessments while wearing a standard Oxford shoe.

    Device: Oxford Shoe

  • Experimental
    Walking/Running Shoe

    Participants complete walking and balance assessments while wearing a walking/running shoe.

    Device: Walking/Running Shoe

  • Experimental
    Rocker Shoe

    Participants complete walking and balance assessments while wearing a rocker shoe.

    Device: Rocker Shoe

Interventions

  • DeviceOwn Footwear

    Participants wear their own regularly used footwear while completing gait and standing assessments in a motion analysis laboratory.

  • DeviceOxford Shoe

    Participants wear a standard Oxford shoe while completing gait and standing assessments in a motion analysis laboratory.

  • DeviceWalking/Running Shoe

    Participants wear a walking/running shoe while completing gait and standing assessments in a motion analysis laboratory.

  • DeviceRocker Shoe

    Participants wear a rocker shoe while completing gait and standing assessments in a motion analysis laboratory.

06

What researchers measure

Primary outcomes

  1. Gait speed

    Gait speed measured using three-dimensional motion capture and force plate analysis during walking under each footwear condition.

    Time frame: Baseline (single laboratory assessment)

  2. Stride length

    Stride length measured using three-dimensional motion capture during walking under each footwear condition.

    Time frame: Baseline (single laboratory assessment)

  3. Cadence

    Cadence measured using three-dimensional motion capture during walking under each footwear condition.

    Time frame: Baseline (single laboratory assessment)

  4. Prosthetic foot clearance during swing phase

    Prosthetic foot clearance during swing phase measured using three-dimensional motion capture under each footwear condition.

    Time frame: Baseline (single laboratory assessment)

  5. Foot clearance time

    Foot clearance time measured using three-dimensional motion capture under each footwear condition.

    Time frame: Baseline (single laboratory assessment)

  6. Ground reaction forces

    Ground reaction forces measured using force plate analysis during walking under each footwear condition.

    Time frame: Baseline (single laboratory assessment)

  7. Stance phase duration

    Stance phase duration measured using three-dimensional motion capture and force plate analysis under each footwear condition.

    Time frame: Baseline (single laboratory assessment)

  8. Ankle power generated by the prosthetic foot

    Ankle power generated by the prosthetic foot measured using three-dimensional motion capture and force plate analysis during walking under each footwear condition.

    Time frame: Baseline (single laboratory assessment)

Secondary outcomes

  1. Perceived footwear comfort

    Participant-rated comfort for each footwear condition using a 100 mm Visual Analogue Scale (VAS), anchored from "Extremely Uncomfortable" to "Extremely Comfortable".

    Time frame: Immediately after each footwear condition during the baseline laboratory assessment.

  2. Perceived footwear stability

    Participant-rated stability for each footwear condition using a 100 mm Visual Analogue Scale (VAS), anchored from "Very Unstable" to "Very Stable".

    Time frame: Immediately after each footwear condition during the baseline laboratory assessment.

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: Undecided — The study team has not yet made a final decision regarding the sharing of individual participant data (IPD). Any future data sharing will be subject to participant consent, ethical approval requirements, institutional policies, and data protection regulations. If data are shared, all information will be de-identified to protect participant confidentiality.

No publications or documents are linked to this record.

09

Updates

1 registry update since Sep 25, 2026
Start date
Sep 1, 2026→Nov 3, 2026
Oct 23, 2026
Show all 1 update
  1. Oct 23, 2026
    Start date Sep 1, 2026→Nov 3, 2026

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07685496
Lead sponsor
University of Salford
Responsible party
Sponsor
First posted
Jul 6, 2026
Start date
Nov 3, 2026 (estimated)
Primary completion
Dec 15, 2026 (estimated)
Completion
Jan 15, 2027 (estimated)
Last update
Oct 23, 2026

Study contacts

Abdulaziz Alkanderi, PhD Candidate
Contact
A.Alkanderi1@edu.salford.ac.uk
+447443673361

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion